CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 77 enrolled
Drug / intervention
BioMonitor 2 Insertable Cardiac Monitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02756338
NCT02756338N/ACompleted
CompareCT.gov

BioMonitor 2 In-Office Setting Insertion Safety and Feasibility Evaluation With Device Functionality Assessment

Biotronik, Inc.·observational·Posted Apr 29, 2016·Updated Oct 26, 2018

In Brief

An observational study evaluating BioMonitor 2 Insertable Cardiac Monitor for Insertable Cardiac Monitor. Completed, enrolled 77 participants across 6 sites.

Detailed Summary

The purpose of this study is to evaluate the safety and feasibility of performing the BioMonitor 2 insertion procedure in an office setting.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInsertable Cardiac Monitor
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedApr 29, 2016
Enrollment StartJun 1, 2016
Primary CompletionJul 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 10.2 years ago

Interventions

BioMonitor 2 Insertable Cardiac Monitordevice